CGI Pharmaceuticals Inc. has raised $62 million in private equity financing from premier venture firms. In April 2000, the Company raised $5 million in Series A financing with CHL Medical Partners and Connecticut Innovations, Inc. (CII) leading the round. A $22 million Series B round followed in March 2001 and was led by MPM Capital, together with new investors Flagship Ventures and Vector Fund Management, as well existing investors CHL and CII.

In June 2004, the company completed a Series C private equity financing, raising $35 million. The Series C round was led by Lilly BioVentures and was joined by new investors CDP Capital, Coastview Capital, Emerging Technology Partners, RiverVest Venture Partners and Toucan Capital Corporation, as well as previous investors CII, Flagship Ventures, MPM Capital, and Vector Fund Management.

 
Copyright 2008 CGI Pharmaceuticals, Inc.